This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Public advisory

"Control-Max," an unauthorized product sold for sexual enhancement, may pose serious health risks

Starting date:
December 9, 2016
Type of communication:
Advisory
Subcategory:
Drugs
Source of recall:
Health Canada
Identification number:
RA-61378

Issue

Health Canada is advising Canadians that the unauthorized product “Control-Max” may pose serious health risks as it is labelled to contain a prescription drug (yohimbine). The product was being sold online by the company RGR Canada Inc.

What you should do

  • Stop using this product. Consult with your health care professional if you have used this product and have health concerns.
  • Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit DIN, DIN-HM or NPN. You can also check if products have been authorized for sale by searching Health Canada’s Drug Product Database and Licensed Natural Health Product Database.
  • Report adverse events to health products to Health Canada by calling toll-free at 1-866-234-2345, or by reporting online, by mail or by fax.

Who is affected

Consumers who have bought or used the product.

Affected product

Control-Max

Background

Yohimbine is a prescription drug and should be used only under the supervision of a health care professional. The use of drugs containing yohimbine (either as yohimbine hydrochloride or yohimbe bark extract) may result in serious adverse reactions, particularly in people with high blood pressure, or heart, kidney or liver disease. Side effects associated with yohimbine include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, or pregnant or nursing women.

Media enquiries

Health Canada

(613) 957-2983

Public enquiries

(613) 957-2991

1-866 225-0709

What Health Canada is doing

Health Canada has requested RGR Canada Inc. to recall the product. Health Canada will take additional action if necessary to prevent further sale of this product in Canada.

Images

Select thumbnail to enlarge - opens in a new window